Literature DB >> 11809893

An insight into the active site of a type I DNA topoisomerase from the kinetoplastid protozoan Leishmania donovani.

Aditi Das1, Chhabinath Mandal, Arindam Dasgupta, Tanushri Sengupta, Hemanta K Majumder.   

Abstract

DNA topoisomerases are ubiquitous enzymes that govern the topological interconversions of DNA thereby playing a key role in many aspects of nucleic acid metabolism. Recently determined crystal structures of topoisomerase fragments, representing nearly all the known subclasses, have been solved. The type IB enzymes are structurally distinct from other known topoisomerases but are similar to a class of enzymes referred to as tyrosine recombinases. A putative topoisomerase I open reading frame from the kinetoplastid Leishmania donovani was reported which shared a substantial degree of homology with type IB topoisomerases but having a variable C-terminus. Here we present a molecular model of the above parasite gene product, using the human topoisomerase I crystal structure in complex with a 22 bp oligonucleotide as a template. Our studies indicate that the overall structure of the parasite protein is similar to the human enzyme; however, major differences occur in the C-terminal loop, which harbors a serine in place of the usual catalytic tyrosine. Most other structural themes common to type IB topoisomerases, including secondary structural folds, hinged clamps that open and close to bind DNA, nucleophilic attack on the scissile DNA strand and formation of a ternary complex with the topoisomerase I inhibitor camptothecin could be visualized in our homology model. The validity of serine acting as the nucleophile in the case of the parasite protein model was corroborated with our biochemical mapping of the active site with topoisomerase I enzyme purified from L.donovani promastigotes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11809893      PMCID: PMC100284          DOI: 10.1093/nar/30.3.794

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  33 in total

1.  Purification and characterization of the DNA untwisting enzyme from rat liver.

Authors:  J J Champoux; B L McConaughy
Journal:  Biochemistry       Date:  1976-10-19       Impact factor: 3.162

Review 2.  DNA topoisomerases as anticancer drug targets.

Authors:  E Schneider; Y H Hsiang; L F Liu
Journal:  Adv Pharmacol       Date:  1990

3.  Topoisomerase I has a strong binding preference for a conserved hexadecameric sequence in the promoter region of the rRNA gene from Tetrahymena pyriformis.

Authors:  A H Andersen; E Gocke; B J Bonven; O F Nielsen; O Westergaard
Journal:  Nucleic Acids Res       Date:  1985-03-11       Impact factor: 16.971

4.  Covalent bonds between protein and DNA. Formation of phosphotyrosine linkage between certain DNA topoisomerases and DNA.

Authors:  Y C Tse; K Kirkegaard; J C Wang
Journal:  J Biol Chem       Date:  1980-06-25       Impact factor: 5.157

5.  cDNA cloning of human DNA topoisomerase I: catalytic activity of a 67.7-kDa carboxyl-terminal fragment.

Authors:  P D'Arpa; P S Machlin; H Ratrie; N F Rothfield; D W Cleveland; W C Earnshaw
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

6.  Inhibition of topoisomerases in African trypanosomes.

Authors:  T A Shapiro
Journal:  Acta Trop       Date:  1993-09       Impact factor: 3.112

7.  Structural flexibility in human topoisomerase I revealed in multiple non-isomorphous crystal structures.

Authors:  M R Redinbo; L Stewart; J J Champoux; W G Hol
Journal:  J Mol Biol       Date:  1999-09-24       Impact factor: 5.469

8.  A structural model for the ternary cleavable complex formed between human topoisomerase I, DNA, and camptothecin.

Authors:  J E Kerrigan; D S Pilch
Journal:  Biochemistry       Date:  2001-08-21       Impact factor: 3.162

9.  Mapping of the active site tyrosine of eukaryotic DNA topoisomerase I.

Authors:  W K Eng; S D Pandit; R Sternglanz
Journal:  J Biol Chem       Date:  1989-08-15       Impact factor: 5.157

10.  Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I.

Authors:  Y H Hsiang; R Hertzberg; S Hecht; L F Liu
Journal:  J Biol Chem       Date:  1985-11-25       Impact factor: 5.157

View more
  3 in total

1.  2-Alkynoic fatty acids inhibit topoisomerase IB from Leishmania donovani.

Authors:  Néstor M Carballeira; Michelle Cartagena; David Sanabria; Deniz Tasdemir; Christopher F Prada; Rosa M Reguera; Rafael Balaña-Fouce
Journal:  Bioorg Med Chem Lett       Date:  2012-08-10       Impact factor: 2.823

2.  Topoisomerase I amino acid substitutions, Gly185Arg and Asp325Glu, confer camptothecin resistance in Leishmania donovani.

Authors:  Jean-François Marquis; Isabelle Hardy; Martin Olivier
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

3.  Deletion study of DNA topoisomerase IB from Leishmania donovani: searching for a minimal functional heterodimer.

Authors:  Rosario Díaz González; Yolanda Pérez Pertejo; David Ordóñez; Rafael Balaña-Fouce; Rosa M Reguera
Journal:  PLoS One       Date:  2007-11-14       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.